• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

XPRO India Ltd
Industry :  Packaging
BSE Code
ISIN Demat
Book Value()
590013
INE445C01015
304.8457484
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
XPROINDIA
86.33
3108.3
EPS(TTM)
Face Value()
Div & Yield %
15.34
10
0.15
 

Conart Engineers bags Rs 15 cr order from Apothecon Pharmaceuticals
May 27,2026
The contract involves civil construction work for LVAPI-6 services at PO Dabhasa, Padra, Vadodara district, Gujarat, and is scheduled to be executed within 12 months from the date of the purchase order.

The company stated that neither its promoters nor promoter group entities have any interest in the awarding authority, adding that the transaction does not qualify as a related-party transaction.

Conart Engineers is engaged in providing engineering, procurement, and construction (EPC) and contracting services for industrial, commercial, and infrastructure projects.

The company reported a 190.5% surge in consolidated net profit to Rs 0.61 crore on a 10.24% increase in revenue to Rs 15.61 crore in Q3 FY26 as compared with Q3 FY25.